Issue for Week of September 7, 2003 / Vol. 3 No. 36

FDA Grants Fast-Track Status to Provenge for Advanced Prostate Cancer Study: Oral Sodium Clodronate May Slow Development of Bone Cancer Two Antibodies May Be Useful in New Prostate Cancer Diagnostic Tests